Dr Branwen Morgan

Branwen has a PhD in medicine from UNSW (Garvan Institute of Medical Research) and is well-known as a science strategy and corporate affairs consultant.

She has worked for a variety of not-for-profit and industry organisations in the UK and Australia – including the Coalition for Medical Progress, an umbrella organisation that was absorbed into Understanding Animal Research UK, and AstraZeneca (AZ) Australia NZ. At AZ, she led and managed a variety of business projects that encompassed company restructuring, new sales initiatives, and the design and development of a company news app.

Branwen's consulting clients include: Amgen, L.E.K. Consulting, CSIRO, The Royal Flying Doctors, The George Institute, Clinical Trials Australia, University of Technology Sydney, and Innovation Science Australia amongst others. Her STEMM network, biomedical knowledge and strong interest in research translation has seen her employed as a communications professional and a journalist by Springer Nature and the ABC. She is a past Board member of Science Technology Australia and a 2022 recipient of a WILD (Women in Leadership Development) scholarship.

Prior to joining CSIRO in 2021, Branwen was the general manager of AusGEM - a joint venture between UTS and the NSW Department of Primary Industries. This led to an increased interest in antimicrobial resistance and her becoming a co-founder and managing director of the UTS-led OUTBREAK project, focusing on One Health antimicrobial resistance (AMR) surveillance that received MRFF funding.

Articles, commentaries and opinion pieces

Nature, Nature Index and Nature Medicine, ABC News in Science, Cosmos, The Australian, Sydney Morning Herald, BBC News online, Australian Doctor, Australian Medicine, The Conversation, Trends in Neurosciences, New Scientist, Today’s Life Sciences, Australasian Science, Lab News, BioMedNet, The Scientist, and Newton 

Recent conference presentations and invitations

Joint ATSE - Victorian Parliamentary Library Science & Technology briefing on AMR, 30 May 2024, Melbourne. Invited Speaker.

Australia’s Vaccine Value Chain Conference, 21-22 May, 2024, Sydney. Session Chair.

Novel Diagnostics for Infectious Diseases, 25-26 March, 2024, London. Invited speaker.

Pathology Technology in Healthcare Congress, March 11, 2024, Sydney. Invited panellist.

AusBioTech 2023, 30 October - 1 November, 2023. Panel Chair.

SXSW Sydney. How tech will mitigate the next pandemic. Oct 18, 2023, Sydney. Panel Speaker.

EU Delegation to India and the Embassy of Sweden on 'One Health Approach to Antimicrobial Resistance: environment and manufacturing industry' to be held at the Embassy of Sweden on Monday, 24 April 2023. Panel speaker.

AMR: From Acknowledgement to Action, Launch of Health Security Systems Australia (a Division of DMTC), April 6, 2022. Panel Speaker.

International Animal Health Asia conference (19-20 October 2021). Speaker.

Antimicrobial drug discovery for fungal diseases and Gram-negative bacteria. University of Sydney workshop. 15 October 15, 2021. Guest speaker.

6th World One Health Congress (Speaker, 2020)

AI, Machine Learning & Robotics in Health (Speaker 2019)

Invited workshop: Towards a human and animal health risk assessment for foodborne and environmental antimicrobial resistance. Niagara Falls, 2019 (Sponsored by Agriculture and Agri-Food Canada)